Regulatory News:
In accordance with Article 14 of the Belgian Transparency law of
May 2, 2007, Azelis Group NV announces that it has received the
following transparency notification on May 22, 2024:
- Transparency notification from Temasek Holdings (Private)
Limited
1. Summary of the
notification
Temasek Holdings (Private) Limited reported in a notification
dated May 22, 2024, that on May 21, 2024, following an acquisition
of voting securities, its shareholding crossed the threshold of
3.00% in Azelis Group NV.
On May 21, 2024, Temasek Holdings (Private) Limited (taking into
account the holding of its affiliates) owned 10,526,313 shares with
voting rights, representing 4.32% of the total number of shares
issued by the company (243,921,719).
2. Content of the
notification
Reason for the notification
Acquisition or disposal of voting securities or voting
rights
Notification by
A parent undertaking or a controlling person
Persons subject to the notification requirement
Name
Address (for legal
entities)
Temasek Holdings (Private) Limited
60B Orchard Road, #06-18, The
Atrium@Orchard, Singapore 238891
Ellington Investments Pte. Ltd.
60B Orchard Road, #06-18, The
Atrium@Orchard, Singapore 238891
Bartley Investments Pte. Ltd. ‐
60B Orchard Road, #06-18, The
Atrium@Orchard, Singapore 238891
Tembusu Capital Pte. Ltd. +
60B Orchard Road, #06-18, The
Atrium@Orchard, Singapore 238891
Date on which the threshold is crossed
May 21, 2024
Threshold that is crossed (in %)
3%
Denominator
243,921,719
Notified Details
A) Voting rights
Previous notification
After the transaction
# voting rights
# voting rights
% voting rights
Holders of voting rights
Linked to securities
Not linked to securities
Linked to securities
Not linked to securities
Temasek Holdings (Private) Limited
0
0,00%
Aranda Investments Pte. Ltd.
3,157,893
1.29%
Ellington Investments Pte. Ltd.
7,368,420
3.02%
Subtotal
10,526,313
4.32%
TOTAL
10,526,313
0
4.32%
0,00%
B) Equivalent financial
instruments
After the transaction
Holders of equivalent
financial instruments
Type of financial
instrument
Expiration date
Exercise period or
date
# voting rights that may be
acquired if the instrument is exercised
% voting rights
Settlement
0,00%
TOTAL
0,00%
TOTAL (A & B)
# of voting rights
% of voting rights
CALCULATE
10,526,313
4.32%
Chain of controlled undertakings through which the holding is
effectively held, if applicable
Aranda Investments Pte. Ltd. is wholly
owned by Seletar Investments Pte Ltd, which is wholly owned by
Temasek Capital (Private) Limited, which is wholly owned by Temasek
Holdings (Private) Limited.
Ellington Investments Pte. Ltd. is wholly
owned by Bartley Investments Pte. Ltd., which is wholly owned by
Tembusu Capital Pte. Ltd., which is wholly owned by Temasek
Holdings (Private) Limited.
3. Further information
The full transparency notification as well as this press release
can be consulted on the Azelis Group NV’s website
About Azelis
Azelis is a leading global innovation service provider in the
specialty chemical and food ingredients industry, present in 65
countries across the globe with over 4,200 employees. Our
knowledgeable teams of industry, market and technical experts are
each dedicated to a specific market within Life Sciences and
Industrial Chemicals. We offer a lateral value chain of
complementary products to more than 63,000 customers, supported by
+2,800 principal relationships, creating a turnover of €4.2 billion
(2023). Azelis Group NV is listed on Euronext Brussels under ticker
AZE.
Across our extensive network of more than 70 application
laboratories, our award-winning staff help develop formulations and
provide technical guidance throughout the customers’ product
development process. We combine a global market reach with a local
footprint to offer a reliable, integrated, and unique digital
service to local customers and attractive -business opportunities
to principals. Top industry-rated by Sustainalytics, Azelis is a
leader in sustainability. We believe in building and nurturing
solid, honest and transparent relationships with our people and
partners.
Impact through ideas. Innovation through formulation.
www.azelis.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240524752839/en/
For more information, please contact: Azelis
investor-relations@azelis.com